Trial finds new drug combo increases remission time for lymphoma patients ecancermedicalscience A trial led by French researchers has found that patients under 60 with a form of non-Hodgkin's lymphoma called 'diffuse large B-cell lymphoma' are more likely to have a longer remission if they were given a combined treatment of the drug rituximab ... |
